Metabolomics

Dataset Information

0

Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Breast Cancer Cells

DISEASE(S): Cancer

PROVIDER: ST002317 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

Json Xml

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

Proteomics Mass spectroscopy-based proteomics and metabolomics analysis of BT- 474 breast cancer cells treated with Tamoxifen and/or Trastuzumab
2023-01-17 | PXD033145 | Pride
Metabolomics Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with trastuzumab
| ST002318 | MetabolomicsWorkbench
Metabolomics Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen and trastuzumab
| ST002319 | MetabolomicsWorkbench
Unknown Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells.
| S-EPMC4388387 | biostudies-literature
Proteomics Proteomics of Triple Negative Breast Cancer Cells Treated with SU056
2024-04-04 | PXD042380 | Pride
Unknown Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.
| S-EPMC8010400 | biostudies-literature
Unknown Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.
| S-EPMC5955814 | biostudies-literature
Unknown The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells.
| S-EPMC8632082 | biostudies-literature
Unknown Comparative metabolomics of MCF-7 breast cancer cells using different extraction solvents assessed by mass spectroscopy.
| S-EPMC6739366 | biostudies-literature
Unknown Predicting response and survival in chemotherapy-treated triple-negative breast cancer.
| S-EPMC4200088 | biostudies-literature